Table 1 Study patients, cardiopulmonary bypass (perfusion) time, aortic cross-clamp time, coronary flow velocity (PFVd, in cm.s -1 ), and pre- and post-operative (6 ± 1 days) QTc, QTd and PQ measurements
Patient | Age (mo) gender diagnosis | Bypass time (min) | Aortic cross-clamp time (min) | Pre-op LAD PFVd | Post-op LAD PFVd | Δ | Pre-op QTc (ms) | Post-op QTc (ms) | Δ | Pre-op QTd (ms) | Post-op QTd (ms) | Δ | Pre-op PQ (ms) | Post-op PQ (ms) | Δ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 72, F ASD-SV | 82 | 39 | 50 | 65 | +15 (30%) | 412 | 409 | -3 (<1%) | 40 | 30 | -10 (25%) | 138 | 132 | -6 (4%) |
2 | 36, F ASD-2 | 58 | 14 | 43 | 67 | +24 (56%) | 394 | 393 | -1 (<1%) | 40 | 60 | +20 (50%) | 130 | 136 | +6 (5%) |
3 | 48, F ASD-2 | 168 | 26 | 40 | 90 | +50 (125%) | 415 | 451 | +36 (9%) | 30 | 50 | +20 (67%) | 150 | 194 | +44 (30%) |
4 | 60, F ASD-2 | 46 | 21 | 28 | 70 | +42 (150%) | 427 | 419 | -8 (2%) | 60 | 40 | -20 (33%) | 136 | 118 | -18 (13%) |
5 | 24, M ASD-2 | 64 | 31 | 36 | 57 | +21 (58%) | 374 | 392 | +18 (5%) | 40 | 40 | 0 | 134 | 144 | +10 (7%) |
6 | 15, F ASD-2 | 73 | 53 | 49 | 70 | +21 (43%) | 411 | 384 | -27 (7%) | 40 | 30 | -10 (25%) | 164 | 130 | -34 (21%) |
7 | 32, M ASD-2 | 108 | 60 | 53 | 93 | +40 (75%) | 413 | 418 | +5 (1%) | 60 | 60 | 0 | 130 | 92 | -38 (29%) |
8 | 12, M ASD-2 | na | na | 56 | 62 | +6 (11%) | 413 | 369 | -44 (11%) | 40 | 30 | -10 (25) | 136 | 100 | -36 (26%) |
9 | 84, M ASD-2 | 52 | 24 | 50 | 66 | +16 (32%) | 398 | 390 | -8 (2%) | 60 | 40 | -20 (33%) | 138 | 124 | -14 (10%) |
10 | 24, M ASD-1 | 53 | 26 | 42 | 52 | +10 (24%) | 375 | 401 | +26 (7%) | 30 | 40 | +10 (33%) | 134 | 134 | 0 |
11 | 48, M ASD-1 | 106 | 67 | 48 | 73 | +25 (52%) | 444 | 432 | -12 (3%) | 40 | 60 | +20 (50%) | 200 | 189 | -11 (6%) |
12 | 48, F ASD-2 | 56 | 25 | 55 | 85 | +30 (54%) | 421 | 448 | +27 (6%) | 40 | 20 | -20 (50%) | 126 | 150 | +24 (10%) |